These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 1877820

  • 41. [Intraperitoneal high-dose cisplatinum chemotherapy (CDDP-ip) in patients with carcinomatous peritonitis].
    Noda T, Oku M, Kiyozuka Y, Ninomiya Y, Hino K, Okamura Y, Maruyama M, Ichijo M.
    Gan To Kagaku Ryoho; 1987 Apr; 14(4):1025-32. PubMed ID: 3566301
    [Abstract] [Full Text] [Related]

  • 42. Intravenous chemotherapy, early debulking surgery, and consolidation intraperitoneal chemotherapy in advanced ovarian carcinoma.
    Tournigand C, Louvet C, Molitor JL, Dehni N, Lejeune V, Sezeur A, Pigne A, Marpeau L, Cady J, de Gramont A.
    Gynecol Oncol; 2001 Nov; 83(2):198-204. PubMed ID: 11606072
    [Abstract] [Full Text] [Related]

  • 43. [A case of stage IV gastric cancer responding to combined chemotherapy by intravenous, intraarterial and intraperitoneal injection].
    Washizawa N, Tokura N, Kase H, Ogawa M, Hattori T, Teramoto T, Kobayashi K, Hirano K.
    Gan To Kagaku Ryoho; 2000 Nov; 27(13):2129-33. PubMed ID: 11103247
    [Abstract] [Full Text] [Related]

  • 44. [Chemotherapy with consecutive low-dose CDDP combined with 5-FU for gynecologic malignancies].
    Shimizu Y, Hasumi K.
    Gan To Kagaku Ryoho; 1999 Oct; 26(11):1564-74. PubMed ID: 10553414
    [Abstract] [Full Text] [Related]

  • 45. Evaluation of an intraperitoneal chemotherapy program implemented at the Princess Margaret Hospital for patients with epithelial ovarian carcinoma.
    Chin SN, Pinto V, Rosen B, Oza A, Dodge J, Murphy J, Mackay H.
    Gynecol Oncol; 2009 Mar; 112(3):450-4. PubMed ID: 19135709
    [Abstract] [Full Text] [Related]

  • 46. Pharmacology of 21-day oral etoposide given in combination with i.v. cisplatin in patients with extensive-stage small cell lung cancer: a cancer and leukemia group B study (CALGB 9062).
    Miller AA, Rosner GL, Ratain MJ, Hollis DR, Green MR, Schilsky RL.
    Clin Cancer Res; 1997 May; 3(5):719-25. PubMed ID: 9815741
    [Abstract] [Full Text] [Related]

  • 47. [Intraperitoneal infusion therapy of MTX and 5-FU for advanced gastric cancer and its peritoneal metastasis].
    Takamatsu S, Maruyama M, Sugano N, Katada M, Ebuchi M.
    Gan To Kagaku Ryoho; 1995 Sep; 22(11):1619-21. PubMed ID: 7574775
    [Abstract] [Full Text] [Related]

  • 48. [Pharmacokinetics following intraperitoneal infusion of cisplatinum with and without sodium thiosulfate rescue in carcinomatous peritonitis in advanced gastric cancers].
    Namatame K, Kou Y, Nakayoshi A.
    Gan To Kagaku Ryoho; 1991 Aug; 18(11):1784-9. PubMed ID: 1877818
    [Abstract] [Full Text] [Related]

  • 49. Intraperitoneal administration of cisplatin and 5-fluorouracil in residual ovarian cancer: a Phase II Gynecologic Oncology Group trial.
    Braly PS, Berek JS, Blessing JA, Homesley HD, Averette H.
    Gynecol Oncol; 1995 Feb; 56(2):164-8. PubMed ID: 7896179
    [Abstract] [Full Text] [Related]

  • 50. [Intraperitoneal repeated chemotherapy using CDDP combined with MMC for carcinomatous peritonitis].
    Arai K, Kitamura M, Miyashita K.
    Gan To Kagaku Ryoho; 1993 Aug; 20(11):1642-4. PubMed ID: 8373237
    [Abstract] [Full Text] [Related]

  • 51. Identification of prognostic factors after positive second-look surgery in epithelial ovarian carcinoma.
    McCreath WA, Eisenhauer EL, Abu-Rustum NR, Venkatraman ES, Caceres A, Bier R, Huh J, Cho J, Barakat RR, Chi DS.
    Gynecol Oncol; 2006 Jul; 102(1):8-14. PubMed ID: 16427689
    [Abstract] [Full Text] [Related]

  • 52. Population pharmacokinetics of cisplatin in patients with advanced ovarian cancer during intraperitoneal hyperthermia chemotherapy.
    Panteix G, Beaujard A, Garbit F, Chaduiron-Faye C, Guillaumont M, Gilly F, Baltassat P, Bressolle F.
    Anticancer Res; 2002 Jul; 22(2B):1329-36. PubMed ID: 12168946
    [Abstract] [Full Text] [Related]

  • 53. Experience with implanted subcutaneous ports for intraperitoneal chemotherapy in ovarian cancer.
    Malmström H, Carstensen J, Simonsen E.
    Gynecol Oncol; 1994 Jul; 54(1):27-34. PubMed ID: 8020835
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Intraperitoneal carboplatin and etoposide for persistent epithelial ovarian cancer: analysis of results by prior sensitivity to platinum-based regimens.
    Muggia FM, Groshen S, Russell C, Jeffers S, Chen SC, Schlaerth J, Curtin J, Morrow CP.
    Gynecol Oncol; 1993 Aug; 50(2):232-8. PubMed ID: 8375739
    [Abstract] [Full Text] [Related]

  • 57. CA125 level as a predictor of progression-free survival and overall survival in ovarian cancer patients with surgically defined disease status prior to the initiation of intraperitoneal consolidation therapy.
    Juretzka MM, Barakat RR, Chi DS, Iasonos A, Dupont J, Abu-Rustum NR, Poynor EA, Aghajanian C, Spriggs D, Hensley ML, Sabbatini P.
    Gynecol Oncol; 2007 Jan; 104(1):176-80. PubMed ID: 16996584
    [Abstract] [Full Text] [Related]

  • 58. Phase II trial of intraperitoneal cisplatin with intravenous doxorubicin and cyclophosphamide in previously untreated patients with advanced ovarian cancer-long-term follow-up.
    Morgan RJ, Braly P, Cecchi G, Leong L, Shibata S, Margolin K, Somlo G, McNamara M, Longmate J, Schinke S, Raschko J, Nagasawa S, Kogut N, Parker P, Stein A, Cho J, Smith E, Coluzzi P, Najera L, Johnson D, Womack E, Doroshow JH.
    Gynecol Oncol; 1999 Dec; 75(3):419-26. PubMed ID: 10600300
    [Abstract] [Full Text] [Related]

  • 59. [Pharmacokinetics of carboplatin after intraperitoneal administration and clinical effect in ovarian cancer].
    Ohno M, Hirokawa M, Hando T.
    Gan To Kagaku Ryoho; 1992 Dec; 19(14):2355-61. PubMed ID: 1463342
    [Abstract] [Full Text] [Related]

  • 60. [Usefulness of intraperitoneal carboplatin administration-- pharmacokinetic analysis].
    Ito K, Itani Y, Furuki K, Tamori N, Noda T, Adachi S, Hirano Y, Kato Y, Kiyozuka Y.
    Nihon Sanka Fujinka Gakkai Zasshi; 1992 Sep; 44(9):1180-6. PubMed ID: 1453047
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.